LATITUDE Study HIV: UAB NEJM Breakthrough | AcademicJobs
NEJM publishes UAB-led LATITUDE study showing monthly cabotegravir-rilpivirine injections superior for HIV patients with adherence challenges, slashing regimen failure by nearly half.
No reviews yet. Be the first to rate Aadia!
Dr. Aadia Rana is Professor of Medicine in the Division of Infectious Diseases at the University of Alabama at Birmingham Heersink School of Medicine. She serves as Director of the Implementation and Community Sciences Core at the UAB Center for AIDS Research and as co-director of the UAB Center for AIDS Research Ending HIV in Alabama Scientific Working Group. Her research focuses on disparities in access and adherence to medical treatment among people living with HIV, outcomes among women with HIV, and implementation of combination biomedical and behavioral interventions to improve treatment adherence and health outcomes.
Dr. Rana received her medical degree from the University of Alabama School of Medicine. She completed residency training at Case Western Reserve University and a fellowship in infectious diseases and HIV health services research at Brown University. She has held faculty appointments at the University of Alabama at Birmingham, where her work centers on HIV-related implementation science and community-engaged research.
Professional Email: null
NEJM publishes UAB-led LATITUDE study showing monthly cabotegravir-rilpivirine injections superior for HIV patients with adherence challenges, slashing regimen failure by nearly half.